{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:50:37Z","timestamp":1791258637558,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"DOI":"10.1038\/s41401-026-01940-4","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:56:56Z","timestamp":1791255416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protein kinase WEE1 promotes cardiomyocytes ferroptosis and cardiac hypertrophy via the NF-\u03baB\/LCN2 axis"],"prefix":"10.1038","author":[{"given":"Wei-hang","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-pei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-bo","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang-yan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-ji","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-hui","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng-fei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-hai","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"1940_CR1","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","volume":"128","author":"VL Roger","year":"2021","unstructured":"Roger VL. Epidemiology of heart failure: a contemporary perspective. Circ Res. 2021;128:1421\u201334.","journal-title":"Circ Res"},{"key":"1940_CR2","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1161\/CIRCULATIONAHA.123.067097","volume":"149","author":"T Liu","year":"2024","unstructured":"Liu T, Hao Y, Zhang Z, Zhou H, Peng SQ, Zhang DY, et al. Advanced cardiac patches for the treatment of myocardial infarction. Circulation. 2024;149:2002\u201320.","journal-title":"Circulation"},{"key":"1940_CR3","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.2337\/dci22-0014","volume":"45","author":"R Pop-Busui","year":"2022","unstructured":"Pop-Busui R, Januzzi JL, Bruemmer D, Butalia S, Green JB, Horton WB, et al. Heart failure: An underappreciated complication of diabetes. A consensus report of the American diabetes association. Diabetes Care. 2022;45:1670\u201390.","journal-title":"Diabetes Care"},{"key":"1940_CR4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.actbio.2023.05.022","volume":"166","author":"D Guan","year":"2023","unstructured":"Guan D, Zhuan X, Luo X, Gao H. An updated lagrangian constrained mixture model of pathological cardiac growth and remodelling. Acta Biomater. 2023;166:375\u201399.","journal-title":"Acta Biomater"},{"key":"1940_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104863","volume":"98","author":"K Qian","year":"2023","unstructured":"Qian K, Tang J, Ling YJ, Zhou M, Yan XX, Xie Y, et al. Exogenous NADPH exerts a positive inotropic effect and enhances energy metabolism via SIRT3 in pathological cardiac hypertrophy and heart failure. EBioMedicine. 2023;98:104863.","journal-title":"EBioMedicine"},{"key":"1940_CR6","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41586-022-05575-3","volume":"613","author":"JL Johnson","year":"2023","unstructured":"Johnson JL, Yaron TM, Huntsman EM, Kerelsky A, Song JH, Regev A, et al. An atlas of substrate specificities for the human serine\/threonine kinome. Nature. 2023;613:759\u201366.","journal-title":"Nature"},{"key":"1940_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj7251","volume":"10","author":"Z Hu","year":"2024","unstructured":"Hu Z, Chen PH, Li W, Krone M, Zheng SJ, Saarbach J, et al. EGFR targeting PhosTACs as a dual inhibitory approach reveals differential downstream signaling. Sci Adv. 2024;10:eadj7251.","journal-title":"Sci Adv"},{"key":"1940_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12933-024-02254-7","volume":"23","author":"Y Chen","year":"2024","unstructured":"Chen Y, Li S, Guan B, Yan XP, Huang C, Du YQ, et al. MAP4K4 exacerbates cardiac microvascular injury in diabetes by facilitating S-nitrosylation modification of Drp1. Cardiovasc Diabetol. 2024;23:164.","journal-title":"Cardiovasc Diabetol"},{"key":"1940_CR9","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.193733","volume":"10","author":"JP Teuber","year":"2025","unstructured":"Teuber JP, Scissors RE, Subramani A, Madamanchi N, Brody MJ. Rac1 palmitoylation is required for cardiac stress adaptation and regulation of protein kinase A signaling. JCI Insight. 2025;10:e193733.","journal-title":"JCI Insight"},{"key":"1940_CR10","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/CIRCRESAHA.121.319478","volume":"130","author":"Y Yao","year":"2022","unstructured":"Yao Y, Li F, Zhang M, Jin L, Xie P, Liu DR, et al. Targeting CaMKII-\u03b49 ameliorates cardiac ischemia\/reperfusion injury by inhibiting myocardial inflammation. Circ Res. 2022;130:887\u2013903.","journal-title":"Circ Res"},{"key":"1940_CR11","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1161\/CIRCULATIONAHA.121.055920","volume":"145","author":"JX Zhang","year":"2022","unstructured":"Zhang JX, Liang RQ, Wang K, Zhang WJ, Zhang M, Jin L, et al. Novel CaMKII-\u03b4 inhibitor hesperadin exerts dual functions to ameliorate cardiac ischemia\/reperfusion injury and inhibit tumor growth. Circulation. 2022;145:1154\u201368.","journal-title":"Circulation"},{"key":"1940_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156054","volume":"135","author":"T Zhang","year":"2024","unstructured":"Zhang T, Li LL, Mo XT, Xie SY, Liu SQ, Zhao N, et al. Matairesinol blunts adverse cardiac remodeling and heart failure induced by pressure overload by regulating prdx1 and PI3K\/AKT\/FOXO1 signaling. Phytomedicine. 2024;135:156054.","journal-title":"Phytomedicine"},{"key":"1940_CR13","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1021\/acs.jmedchem.2c01448","volume":"66","author":"S Lautala","year":"2023","unstructured":"Lautala S, Provenzani R, Tarvainen I, Sirna K, Karhu T, Grazhdankin E, et al. Expanding the paradigm of structure-based drug design: molecular dynamics simulations support the development of new pyridine-based protein kinase C-targeted agonists. J Med Chem. 2023;66:4588\u2013602.","journal-title":"J Med Chem"},{"key":"1940_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.153951","volume":"98","author":"Y Chen","year":"2022","unstructured":"Chen Y, Li L, Hu C, Zhao X, Zhang P, Chang YX, et al. Lingguizhugan decoction dynamically regulates MAPKs and AKT signaling pathways to retrogress the pathological progression of cardiac hypertrophy to heart failure. Phytomedicine. 2022;98:153951.","journal-title":"Phytomedicine"},{"key":"1940_CR15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI156436","volume":"133","author":"V Garlapati","year":"2023","unstructured":"Garlapati V, Molitor M, Michna T, Harms G, Finger S, Jung R, et al. Targeting myeloid cell coagulation signaling blocks MAP kinase\/TGF-\u03b21-driven fibrotic remodeling in ischemic heart failure. J Clin Invest. 2023;133:e156436.","journal-title":"J Clin Invest"},{"key":"1940_CR16","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.152293","volume":"7","author":"RKM Ponce","year":"2022","unstructured":"Ponce RKM, Thomas NJ, Bui NQ, Kondo T, Okimoto RA. WEE1 kinase is a therapeutic vulnerability in CIC-DUX4 undifferentiated sarcoma. JCI Insight. 2022;7:e152293.","journal-title":"JCI Insight"},{"key":"1940_CR17","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1182\/blood.V124.21.997.997","volume":"124","author":"Y Dai","year":"2014","unstructured":"Dai Y, Zhou L, Zhang Y, Chen S, Kmieciak M, Leng Y, et al. HDAC inhibitors reciprocally interacts the Wee1 inhibitor AZD1775 to abrogate both the G1\/S and G2\/M checkpoints via chk1-related cdc2\/Cdk1 threonine 14 dephosphorylation in AML cells. Blood. 2014;124:997.","journal-title":"Blood"},{"key":"1940_CR18","first-page":"3705","volume":"39","author":"JF Seligmann","year":"2021","unstructured":"Seligmann JF, Fisher DJ, Brown LC, Adams RA, Graham J, Quirke P, et al. Inhibition of WEE1 Is effective inTP53- and RAS-mutant metastatic colorectal cancer: a randomized trial (FOCUS4-C) comparing Adavosertib (AZD1775) with active monitoring. J. Clin Oncol. 2021;39:3705\u201315.","journal-title":"Clin Oncol"},{"key":"1940_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101030","volume":"8","author":"AD Nonneville","year":"2021","unstructured":"Nonneville AD, Finetti P, Birnbaum D, Mamessier E, Bertucci F. WEE1 dependency and pejorative prognostic value in triple-negative breast cancer. Adv Sci. 2021;8:e2101030.","journal-title":"Adv Sci"},{"key":"1940_CR20","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/leu.2014.296","volume":"29","author":"L Zhou","year":"2014","unstructured":"Zhou L, Zhang Y, Chen S, Kmieciak M, Leng Y, Lin H, et al. A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutations. Leukemia. 2014;29:807\u201318.","journal-title":"Leukemia"},{"key":"1940_CR21","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1158\/2326-6066.CIR-21-0587","volume":"10","author":"SS Dinavahi","year":"2022","unstructured":"Dinavahi SS, Chen YC, Punnath K, Berg A, Herlyn M, Foroutan M, et al. Targeting WEE1\/AKT restores p53-dependent natural killer-cell activation to induce immune checkpoint blockade responses in \u201cCold\u201d melanoma. Cancer Immunol Res. 2022;10:757\u201369.","journal-title":"Cancer Immunol Res"},{"key":"1940_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217265","volume":"605","author":"OT Alhalabi","year":"2024","unstructured":"Alhalabi OT, G\u00f6ttmann M, Gold MP, Schlue S, Hielscher T, Iskar M, et al. Integration of transcriptomics, proteomics and loss-of-function screening reveals WEE1 as a target for combination with dasatinib against proneural glioblastoma. Cancer Lett. 2024;605:217265.","journal-title":"Cancer Lett"},{"key":"1940_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06167-3","volume":"14","author":"R Della Monica","year":"2023","unstructured":"Della Monica R, Buonaiuto M, Cuomo M, Pagano C, Trio F, Costabile D, et al. Targeted inhibition of the methyltransferase SETD8 synergizes with the Wee1 inhibitor adavosertib in restraining glioblastoma growth. Cell Death Dis. 2023;14:638.","journal-title":"Cell Death Dis"},{"key":"1940_CR24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cell.2018.02.014","volume":"173","author":"TMA Mohamed","year":"2018","unstructured":"Mohamed TMA, Ang YS, Radzinsky E, Foley A, Magnitsky S, Srivastava D, et al. Regulation of cell cycle to stimulate adult cardiomyocyte proliferation and cardiac regeneration. Cell. 2018;173:104\u201316.e12.","journal-title":"Cell"},{"key":"1940_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abh4181","volume":"7","author":"E Tampakakis","year":"2021","unstructured":"Tampakakis E, Gangrade H, Glavaris S, Htet M, Murphy S, Lin BL, et al. Heart neurons use clock genes to control myocyte proliferation. Sci Adv. 2021;7:eabh4181.","journal-title":"Sci Adv"},{"key":"1940_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25211-4","volume":"12","author":"A Raso","year":"2021","unstructured":"Raso A, Dirkx E, Sampaio-Pinto V, Azzouzi HE, Cubero RJ, Sorensen DW, et al. A microRNA program regulates the balance between cardiomyocyte hyperplasia and hypertrophy and stimulates cardiac regeneration. Nat Commun. 2021;12:4808.","journal-title":"Nat Commun"},{"key":"1940_CR27","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41392-023-01635-w","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, Shao YH, Zhang JM, Wang Y, Zhou M, Li HQ, et al. Macrophage CARD9 mediates cardiac injury following myocardial infarction through regulation of lipocalin 2 expression. Signal Transduct Target Ther. 2023;8:394.","journal-title":"Signal Transduct Target Ther"},{"key":"1940_CR28","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1093\/eurheartj\/ehaf349","volume":"47","author":"M Wang","year":"2026","unstructured":"Wang M, Han X, Wang Q, Wang Y, Zhou M, Li HQ, et al. Checkpoint kinase Wee1 activation drives inflammation and hypertrophy through the protein kinase B\/phosphoinositide 3-kinases-nuclear factor \u03baB pathway in cardiomyocytes. Eur Heart J. 2026;47:1702\u201317.","journal-title":"Eur Heart J"},{"key":"1940_CR29","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.125.075220","volume":"153","author":"X Chen","year":"2026","unstructured":"Chen X, Yu X, Zhong S, Shang P, Li R, Xu XD, et al. ALDH2\/eIF3E interaction modulates protein translation critical for cardiomyocyte ferroptosis in acute myocardial ischemia injury. Circulation. 2026;153:164\u201384.","journal-title":"Circulation"},{"key":"1940_CR30","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/CIRCRESAHA.123.323517","volume":"133","author":"G Ichihara","year":"2023","unstructured":"Ichihara G, Katsumata Y, Sugiura Y, Matsuoka YT, Maeda R, Endo J, et al. MRP1-dependent extracellular release of glutathione induces cardiomyocyte ferroptosis after ischemia-reperfusion. Circ Res. 2023;133:861\u201376.","journal-title":"Circ Res"},{"key":"1940_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45823-w","volume":"15","author":"DY Sun","year":"2024","unstructured":"Sun DY, Wu WB, Wu JJ, Shi Y, Xu JJ, Ouyang SX, et al. Pro-ferroptotic signaling promotes arterial aging via vascular smooth muscle cell senescence. Nat Commun. 2024;15:1429.","journal-title":"Nat Commun"},{"key":"1940_CR32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI175645","volume":"134","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Jiang C, He J, He C, Zhou XL, Huang X, et al. Cirbp suppression compromises DHODH-mediated ferroptosis defense and attenuates hypothermic cardioprotection in an aged donor transplantation model. J Clin Invest. 2024;134:e175645.","journal-title":"J Clin Invest"},{"key":"1940_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2505119","volume":"17","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wei Y, Han X, Shi L, Yu H, Ji XR, et al. Faecalibacterium prausnitzii prevents age-related heart failure by suppressing ferroptosis in cardiomyocytes through butyrate-mediated LCN2 regulation. Gut Microbes. 2025;17:2505119.","journal-title":"Gut Microbes"},{"key":"1940_CR34","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.7150\/ijbs.79915","volume":"19","author":"HS An","year":"2023","unstructured":"An HS, Yoo JW, Jeong JH, Heo MB, Hwang SH, Jang HM, et al. Lipocalin-2 promotes acute lung inflammation and oxidative stress by enhancing macrophage iron accumulation. Int J Biol Sci. 2023;19:1163\u201377.","journal-title":"Int J Biol Sci"},{"key":"1940_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1515\/cclm-2017-0120","volume":"56","author":"Z Sivalingam","year":"2017","unstructured":"Sivalingam Z, Larsen SB, Grove EL, Hvas AM, Kristensen SD, Magnusson NE. Neutrophil gelatinase-associated lipocalin as a risk marker in cardiovascular disease. Clin Chem Lab Med. 2017;56:5\u201318.","journal-title":"Clin Chem Lab Med"},{"key":"1940_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.7150\/ijbs.17758","volume":"13","author":"G Wang","year":"2017","unstructured":"Wang G, Liu S, Wang L, Meng LK, Cui CJ, Zhang H, et al. Lipocalin-2 promotes endoplasmic reticulum stress and proliferation by augmenting intracellular iron in human pulmonary arterial smooth muscle cells. Int J Biol Sci. 2017;13:135\u201344.","journal-title":"Int J Biol Sci"},{"key":"1940_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301928","volume":"10","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Wang Y, Lu Z, Wan JK, Jiang LL, Song DJ, et al. PGAM1 inhibition promotes HCC ferroptosis and synergizes with Anti-PD-1 immunotherapy. Adv Sci. 2023;10:e2301928.","journal-title":"Adv Sci"},{"key":"1940_CR38","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1080\/15548627.2023.2218764","volume":"19","author":"Y Xie","year":"2023","unstructured":"Xie Y, Kang R, Klionsky DJ, Tang D. GPX4 in cell death, autophagy, and disease. Autophagy. 2023;19:2621\u201338.","journal-title":"Autophagy"},{"key":"1940_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02217-2","volume":"24","author":"P Zhao","year":"2025","unstructured":"Zhao P, Yin S, Qiu Y, Sun C, Yu H. Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance. Mol Cancer. 2025;24:23.","journal-title":"Mol Cancer"},{"key":"1940_CR40","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao W, Wang X, Zhou Y, Wang X, Yu Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther. 2022;7:196.","journal-title":"Signal Transduct Target Ther"},{"key":"1940_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","volume":"20","author":"X Fang","year":"2023","unstructured":"Fang X, Ardehali H, Min J, Wang F. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol. 2023;20:7\u201323.","journal-title":"Nat Rev Cardiol"},{"key":"1940_CR42","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1161\/CIRCRESAHA.122.321667","volume":"132","author":"KT Sawicki","year":"2023","unstructured":"Sawicki KT, De Jesus A, Ardehali H. Iron metabolism in cardiovascular disease: physiology, mechanisms, and therapeutic targets. Circ Res. 2023;132:379\u201396.","journal-title":"Circ Res"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01940-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01940-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01940-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:56:58Z","timestamp":1791255418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01940-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":42,"alternative-id":["1940"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01940-4","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The correspondence author Bao-feng Yang is the associate editor-in-chief of the journal Acta Pharmacologica Sinica, but he has not been involved in the peer-review or decision-making process for this manuscript. Other authors declared no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}